CISplatin (WG Critical Care, LLC)
Welcome to the PulseAid listing for the CISplatin drug offered from WG Critical Care, LLC. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | WG Critical Care, LLC |
NON-PROPRIETARY NAME: | CISplatin |
SUBSTANCE NAME: | CISPLATIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-01-13 |
END MARKETING DATE: | 0000-00-00 |
CISplatin HUMAN PRESCRIPTION DRUG Details:
Item Description | CISplatin from WG Critical Care, LLC |
LABELER NAME: | WG Critical Care, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2012-01-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 44567-509_2308221c-f942-4c1e-a9f9-2ba58c43d362 |
PRODUCT NDC: | 44567-509 |
APPLICATION NUMBER: | NDA018057 |
Other CISPLATIN Pharmaceutical Manufacturers / Labelers: